Investor Overview

Webcast ImageWebcast
CryoLife, Inc. at Morgan Stanley Global Healthcare Conference (Replay)
09/13/16 at 4:40 p.m. ET
Webcast ImageWebcast
CryoLife, Inc. at Ladenburg Thalmann Healthcare Conference (Live)
09/27/16 at 1:30 p.m. ET
Download Corporate Governance Documentation CryoLife Corporate Presentation
Corporate Profile

CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries.  It operates throughout the U.S. and internationally.  CryoLife manufactures and distributes BioGlue® Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels.  BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world.  CryoLife’s BioFoam® Surgical Matrix is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery and on abdominal parenchymal tissues (liver and spleen) when control of bleeding by ligature or conventional methods is ineffective or impractical.  CryoLife distributes PerClot®, a powdered hemostat, in Europe and other select international countries. . . More >>

CRY (Common Stock)
ExchangeNYSE (US Dollar)
Price$17.79
Change (%) Stock is Down 0.03 (0.17%)
Volume125,901
Data as of 09/27/16 12:53 p.m. ET
Refresh quote
Recent NewsMore >>
DateTitle
09/19/16CryoLife to Present at Ladenburg Thalmann 2016 Healthcare Conference
09/17/16CryoLife to Present at Morgan Stanley Global Healthcare Conference
09/17/16CryoLife Appoints James McDermid as Chief Human Resources Officer
Upcoming EventsMore >>
DateTitle
09/27/16 1:30 p.m. ET
CryoLife, Inc. at Ladenburg Thalmann Healthcare Conference
Most Recent SEC FilingsMore >>
Filing DateFormDescriptionFiling GroupDownloads
09/22/164Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
09/16/164Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
09/15/164Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
09/14/163Initial filing by director officer or owner of more than ten percent.3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
09/14/164Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
Data provided by Nasdaq. Minimum 15 minutes delayed.
Receive E-mail Alerts
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!